Telephone
N/A
Address
Level 25 525 Collins Street Melbourne, Victoria (VIC) 3000
Description
N/A
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.3 - 1.44
Trade Value (12mth)
AU$14,295.00
1 week
7.94%
1 month
-22.73%
YTD
-64.58%
1 year
-67.92%
All time high
9
EPS 3 yr Growth
-8.300%
EBITDA Margin
%
Operating Cashflow
-$8m
Free Cash Flow Return
-74.80%
ROIC
-90.90%
Interest Coverage
-63.80
Quick Ratio
2.90
Shares on Issue (Fully Dilluted)
28m
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 October 22 |
Notification regarding unquoted securities - IBX
×
Notification regarding unquoted securities - IBX |
31 October 22 |
Change of Registry Address
×
Change of Registry Address |
31 May 23 |
Notification regarding unquoted securities - IBX
×
Notification regarding unquoted securities - IBX |
31 May 23 |
Cleansing Statement under Section 708A(12C)(e)
×
Cleansing Statement under Section 708A(12C)(e) |
31 May 19 |
Chairman's Address to Shareholders at Annual General Meeting
×
Chairman's Address to Shareholders at Annual General Meeting |
31 May 19 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
31 May 18 |
Chairman's Address to Shareholders at Annual General Meeting
×
Chairman's Address to Shareholders at Annual General Meeting |
31 May 18 |
Investor Presentation
×
Investor Presentation |
31 May 18 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
31 July 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 July 23 |
Letter to Shareholders from the CEO, Dr. Isaac Bright
×
Letter to Shareholders from the CEO, Dr. Isaac Bright |
30 January 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
30 August 23 |
Appendix 4D
×
Appendix 4D |
30 August 23 |
Half-Year Financial Report
×
Half-Year Financial Report |
30 August 23 |
Half-Year Results Release
×
Half-Year Results Release |
30 April 20 |
Annual Report to shareholders
×
Annual Report to shareholders |
30 April 19 |
Annual Report to shareholders
×
Annual Report to shareholders |
29 May 23 |
Cancel - Notification regarding unquoted securities - IBX
×
Cancel - Notification regarding unquoted securities - IBX |
29 July 22 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
28 September 22 |
Prostate cancer research update
×
Prostate cancer research update |
28 October 22 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
28 October 19 |
Investor Presentation
×
Investor Presentation |
28 May 21 |
AGM presentation
×
AGM presentation |
28 May 21 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
28 March 23 |
Notice to IBXOA Option Holders
×
Notice to IBXOA Option Holders |
28 June 23 |
Expanded collaboration with Siemens Healthineers to US
×
Expanded collaboration with Siemens Healthineers to US |
28 January 22 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.